Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
Adentri, African, agonist, antibody, antigen, antihypertensive, Appellate, Arabia, Arresto, Arroyo, aseptic, atazanavir, autoimmune, batch, big, biology, Branford, Calistoga, cancer, CAPRISA, Centre, CGI, Chinese, clause, cleaning, Connecticut, Cougar, delta, disciplined, donut, excise, expiratory, FDIC, foregoing, gel, hematological, hole, indenture, intervene, isoform, Jersey, joined, Justice, kinase, library, line, Lupin, lysyl, mAb, marker, McHutchison, MD, microbiological, monoclonal, Natco, newest, notification, opportunistically, overdue, Pacific, pharmacovigilance, Poland, PrEP, Programme, protein, quickly, Ranbaxy, randomized, Rapidscan, Rapiscan, Referencing, repay, resume, rheumatoid, risky, sampling, Saudi, seismically, Sigmapharm, slated, sought, spanning, spleen, spp, stemming, strictly, submission, suite, superiority, Syk, tecadenoson, timeline, TIS, transmission, tyrosine, unblinded, uninfected, unsatisfied, variety, vasculature, vasodilation, Warning, withBurkholderia
Removed:
accommodate, actuarial, added, aggregated, AJCA, alleged, alleging, burden, cancel, caspase, choice, collectible, compensated, complaint, confidently, constructed, continually, cooperate, Creation, darusentan, deconsolidated, demographic, diluent, dismissing, distinguish, divided, edema, entirety, escalating, expenditure, facilitate, finalized, footprint, fosfomycin, fulfill, GBIC, guaranteeing, guarantor, heart, historic, incomplete, Irish, irrevocably, label, LG, main, Medicinal, misleading, modified, moved, Nycomed, ophthalmic, OSI, pace, parent, partial, promulgated, quantified, realizability, regressing, repatriation, resistant, scheduled, separated, settling, shelf, speculative, struggle, superseded, switching, syndicate, tangible, tier, toxicology, transacting, uncollateralized, unutilized, validated, violated, Westminster, wrong
Filing tables
Filing exhibits
- 10-K Annual report
- 2.3 Agmt. and Plan of Merger Among Registrant, Arroyo Merger Sub, Inc. and Arresto
- 10.7 Amendment No. 1 to Amended and Restated Credit Agreement
- 10.8 Amendment No. 2 to Amended and Restated Credit Agreement
- 10.90 Tenofovir Disoproxil Fumarate Manufacturing Supply Agreement
- 21.1 Subsidiaries of Registrant
- 23.1 Consent of Independent Registered Public Accounting Firm
- 31.1 Certification of CEO, As Required by Rule 13A-14(A) or Rule 15D-14(A)
- 31.2 Certification of CFO, As Required by Rule 13A-14(A) or Rule 15D-14(A)
- 32.1 Certifications of CEO and CFO As Required by Rule 13A-14(B) or Rule 15D-14(B)
Related press release
GILD similar filings
Filing view
External links